UBS Group’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.1M | Buy |
377,237
+163,849
| +77% | +$14.5M | 0.01% | 1998 |
|
|
2025
Q4 | $17.1M | Buy |
213,388
+86,065
| +68% | +$7.21M | ﹤0.01% | 2729 |
|
|
2025
Q3 | $12.4M | Sell |
127,323
-70,694
| -36% | -$5.69M | ﹤0.01% | 3060 |
|
|
2025
Q2 | $13.8M | Sell |
198,017
-74,121
| -27% | -$4.23M | ﹤0.01% | 2772 |
|
|
2025
Q1 | $13.5M | Buy |
272,138
+23,748
| +10% | +$1.5M | ﹤0.01% | 2749 |
|
|
2024
Q4 | $17.4M | Buy |
248,390
+112,646
| +83% | +$9.36M | ﹤0.01% | 2479 |
|
|
2024
Q3 | $14.2M | Sell |
135,744
-23,742
| -15% | -$2.78M | ﹤0.01% | 2087 |
|
|
2024
Q2 | $22.7M | Sell |
159,486
-36,581
| -19% | -$4.22M | 0.01% | 1586 |
|
|
2024
Q1 | $21.9M | Sell |
196,067
-21,692
| -10% | -$2.58M | 0.01% | 1618 |
|
|
2023
Q4 | $28.2M | Buy |
217,759
+53,838
| +33% | +$7.42M | 0.01% | 1349 |
|
|
2023
Q3 | $26.7M | Buy |
163,921
+38,234
| +30% | +$6.72M | 0.01% | 1271 |
|
|
2023
Q2 | $23M | Sell |
125,687
-34,794
| -22% | -$5.01M | 0.01% | 1341 |
|
|
2023
Q1 | $21.4M | Buy |
160,481
+1,384
| +0.9% | +$163K | 0.01% | 1343 |
|
|
2022
Q4 | $12.6M | Sell |
159,097
-2,073
| -1% | -$146K | ﹤0.01% | 1747 |
|
|
2022
Q3 | $9.76M | Buy |
161,170
+36,777
| +30% | +$2.38M | ﹤0.01% | 1811 |
|
|
2022
Q2 | $6.82M | Sell |
124,393
-4,456
| -3% | -$258K | ﹤0.01% | 2111 |
|
|
2022
Q1 | $9.73M | Sell |
128,849
-7,298
| -5% | -$499K | ﹤0.01% | 1960 |
|
|
2021
Q4 | $10.2M | Buy |
136,147
+15,011
| +12% | +$889K | ﹤0.01% | 2125 |
|
|
2021
Q3 | $5.7M | Sell |
121,136
-7,989
| -6% | -$348K | ﹤0.01% | 2528 |
|
|
2021
Q2 | $5.22M | Sell |
129,125
-5,002
| -4% | -$207K | ﹤0.01% | 2632 |
|
|
2021
Q1 | $5.51M | Sell |
134,127
-10,941
| -8% | -$408K | ﹤0.01% | 2490 |
|
|
2020
Q4 | $4.22M | Sell |
145,068
-7,408
| -5% | -$192K | ﹤0.01% | 2628 |
|
|
2020
Q3 | $3.35M | Sell |
152,476
-3,120
| -2% | -$79.6K | ﹤0.01% | 2566 |
|
|
2020
Q2 | $4.33M | Sell |
155,596
-78,682
| -34% | -$1.92M | ﹤0.01% | 2148 |
|
|
2020
Q1 | $4.29M | Sell |
234,278
-25,604
| -10% | -$595K | ﹤0.01% | 2060 |
|
|
2019
Q4 | $6.26M | Buy |
259,882
+17,751
| +7% | +$374K | ﹤0.01% | 2395 |
|
|
2019
Q3 | $4.14M | Buy |
242,131
+20,978
| +9% | +$335K | ﹤0.01% | 2568 |
|
|
2019
Q2 | $3.33M | Buy |
221,153
+7,064
| +3% | +$126K | ﹤0.01% | 2679 |
|
|
2019
Q1 | $4.31M | Buy |
214,089
+3,879
| +2% | +$78.8K | ﹤0.01% | 2325 |
|
|
2018
Q4 | $3.74M | Sell |
210,210
-11,894
| -5% | -$211K | ﹤0.01% | 2445 |
|
|
2018
Q3 | $4.36M | Buy |
222,104
+2,140
| +1% | +$44.1K | ﹤0.01% | 2477 |
|
|
2018
Q2 | $4.36M | Buy |
219,964
+4,703
| +2% | +$103K | ﹤0.01% | 2457 |
|
|
2018
Q1 | $5.29M | Sell |
215,261
-6,704
| -3% | -$176K | ﹤0.01% | 2249 |
|
|
2017
Q4 | $6.37M | Sell |
221,965
-4,514
| -2% | -$142K | ﹤0.01% | 2113 |
|
|
2017
Q3 | $6.19M | Sell |
226,479
-6,307
| -3% | -$140K | ﹤0.01% | 2013 |
|
|
2017
Q2 | $4.88M | Buy |
232,786
+2,483
| +1% | +$52.5K | ﹤0.01% | 2164 |
|
|
2017
Q1 | $4.33M | Buy |
230,303
+2,827
| +1% | +$44.5K | ﹤0.01% | 2205 |
|
|
2016
Q4 | $3.31M | Buy |
227,476
+19,815
| +10% | +$270K | ﹤0.01% | 2445 |
|
|
2016
Q3 | $2.76M | Sell |
207,661
-1,382
| -0.7% | -$16K | ﹤0.01% | 2555 |
|
|
2016
Q2 | $2.25M | Sell |
209,043
-6,481
| -3% | -$69.5K | ﹤0.01% | 2678 |
|
|
2016
Q1 | $2.41M | Buy |
215,524
+30,136
| +16% | +$308K | ﹤0.01% | 2508 |
|
|
2015
Q4 | $1.92M | Buy |
185,388
+4,916
| +3% | +$52.2K | ﹤0.01% | 2828 |
|
|
2015
Q3 | $1.93M | Buy |
180,472
+4,054
| +2% | +$49.4K | ﹤0.01% | 2777 |
|
|
2015
Q2 | $2.09M | Sell |
176,418
-8,375
| -5% | -$97K | ﹤0.01% | 2934 |
|
|
2015
Q1 | $1.76M | Buy |
184,793
+44,090
| +31% | +$456K | ﹤0.01% | 3052 |
|
|
2014
Q4 | $1.44M | Buy |
+140,703
| New | +$1.22M | ﹤0.01% | 3233 |
|
Other funds holding ACLS
VPM
RP
VCM
UBS Group's ACLS Position: Q1 2026 in Review
UBS Group increased its Axcelis (ACLS) stake by 77% in Q1 2026, buying an estimated $14.5M and bringing the position to 377,237 shares worth $35.1M. The position accounts for 0.01% of the portfolio, ranked #1998.
UBS Group first reported a position in ACLS in Q4 2014 and has held it in 46 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- UBS Group held 377,237 shares of Axcelis worth $35.1M as of Q1 2026.
- UBS Group bought 163,849 Axcelis shares in Q1 2026, an estimated $14.5M.
- Axcelis made up 0.01% of UBS Group's portfolio in Q1 2026, its #1998 holding.
- UBS Group first reported a position in Axcelis in Q4 2014 and has held it in 46 quarters since.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.